Charisse Somers
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
Journal: Brain : a journal of neurology
Published: July 27, 2021
Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia.
Journal: Neurobiology of aging
Published: November 30, 2020
Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects.
Journal: Journal of Alzheimer's disease : JAD
Published: March 19, 2019
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging.
Journal: NeuroImage. Clinical
Published: September 13, 2018
The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
Journal: Journal of Alzheimer's disease : JAD
Published: September 05, 2017
Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.
Journal: Biomarkers in medicine
Published: January 24, 2017
No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis.
Journal: Alzheimer's research & therapy
Published: December 08, 2016
Validation of the Semiquantitative Static SUVR Method for 18F-AV45 PET by Pharmacokinetic Modeling with an Arterial Input Function.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 21, 2016
A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
Journal: Journal of Alzheimer's disease : JAD
Published: August 29, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026